Patrick Lamy

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Lamy:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Senior VP, Commercial Strategy Common Stock 0 $0 $54.31 09 Dec 2025 Direct
Akero Therapeutics, Inc. Senior VP, Commercial Strategy Stock Option (Right to Buy) 0 09 Dec 2025 Direct

Insider Reports Filed by Patrick Lamy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKRO Akero Therapeutics, Inc. 09 Dec 2025 8 $0 4 Senior VP, Commercial Strategy 09 Dec 2025, 10:06
AKRO Akero Therapeutics, Inc. 01 Jul 2025 1 -$105,760 4 Senior VP, Commercial Strategy 03 Jul 2025, 18:00
AKRO Akero Therapeutics, Inc. 30 Jun 2025 1 +$4,607 4 Senior VP, Commercial Strategy 02 Jul 2025, 18:00
AKRO Akero Therapeutics, Inc. 20 Jun 2025 1 -$47,766 4 Senior VP, Commercial Strategy 20 Jun 2025, 21:08
AKRO Akero Therapeutics, Inc. 16 Jun 2025 4 -$68,532 4 Senior VP, Commercial Strategy 20 Jun 2025, 09:22
AKRO Akero Therapeutics, Inc. 10 Jun 2025 1 -$49,625 4 Senior VP, Commercial Strategy 12 Jun 2025, 18:32
AKRO Akero Therapeutics, Inc. 02 Jun 2025 5 -$121,778 4 Senior VP, Commercial Strategy 04 Jun 2025, 17:36
AKRO Akero Therapeutics, Inc. 22 May 2025 3 -$22,520 4 Senior VP, Commercial Strategy 23 May 2025, 17:30
AKRO Akero Therapeutics, Inc. 07 May 2025 4 -$180,990 4 Senior VP, Commercial Strategy 09 May 2025, 19:18
AKRO Akero Therapeutics, Inc. 03 Mar 2025 3 -$28,220 4 Senior VP, Commercial Strategy 05 Mar 2025, 18:55
AKRO Akero Therapeutics, Inc. 31 Dec 2024 4 -$201,063 4 Senior VP, Commercial Strategy 29 Jan 2025, 20:43
AKRO Akero Therapeutics, Inc. 16 Dec 2024 3 -$29,130 4 Senior VP, Commercial Strategy 18 Dec 2024, 21:03
AKRO Akero Therapeutics, Inc. 10 Dec 2024 1 -$28,481 4 Senior VP, Commercial Strategy 12 Dec 2024, 20:29
AKRO Akero Therapeutics, Inc. 28 Jun 2024 1 +$4,407 4 Senior VP, Commercial Strategy 02 Jul 2024, 18:56
AKRO Akero Therapeutics, Inc. 11 Jun 2024 1 -$12,883 4 Senior VP, Commercial Strategy 13 Jun 2024, 18:04
AKRO Akero Therapeutics, Inc. 08 Dec 2023 2 $0 4 Senior Vice President, Commercial Strategy 12 Dec 2023, 16:35
AKRO Akero Therapeutics, Inc. 10 Jan 2023 1 $0 4 Senior Vice President, Commercial Strategy 11 Jan 2023, 18:51
AKRO Akero Therapeutics, Inc. 10 Jan 2023 0 $0 3 Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy 11 Jan 2023, 18:49